Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: alan laValley who wrote (18394)	1/30/1999 10:14:00 AM
From: alan laValley	Read Replies (2) \| Respond to of 23519

VLAD: I have thought more on your theory that A/Z is waiting for Viagra to enter the market before launching Muse. While this maybe a marketing strategy, I believe based on the success of Muse in the European countries to date, Muse has kept its market share. We must remember A/Z has a sales force that is respected and accepted by the European medical community and they will accept their products more readily. A/Z strong position in Europe does not compare with the USA position Vivus was dealing with. I maybe wrong, but I still believe A/Z is very concerned about the USA contract, and is using their Ace card as a wedge. Wilson, although realizing A/Z would be their beat partner, is also playing it to the best. Perhaps Wilson feels A/Z has not yet,made their best offer!!!! On the 11th hour things change very rapidly. Just a theory.....Al